Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

cer cells that are no longer responsive to normal growth control mechanisms. Non-proliferating cells are relatively insensitive to Vidaza.

About Epigenetics

Azacitidine is the first of a new class of anti-cancer compounds called epigenetic therapies. DNA methylation and histone deacetylation are two of the more studied epigenetic regulators of gene expression. Epigenetics refers to changes in the regulation of gene expression. Epigenetic changes can silence gene expression and, unlike DNA mutations, may be reversed by targeting the enzymes involved. The silencing of key cell cycle control genes and tumor suppressor genes through these two mechanisms of epigenetic regulation has been demonstrated in vitro and in vivo in hematological malignancies and in solid tumors. These key growth control genes can be re-expressed in cancer cells when DNA hypermethylation is reversed by Vidaza and/or inappropriate histone deacetylation is inhibited by MGCD0103. The epigenetic approach to cancer therapy is that rather than using molecules that kill both normal and tumor cells, the silenced genes are reactivated through targeted epigenetic therapy, re-establishing the cancer cell's natural mechanisms to control abnormal growth.

Important Safety Information

Vidaza is contraindicated in patients with a known hypersensitivity to azacitidine or mannitol and in patients with advanced malignant hepatic tumors.

In clinical studies, the most commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other adverse reactions included dizziness (18.6%), chest pain (16.4%), febrile neutropenia (16.4%), myalgia (15.9%), injection site reaction (13.6%), aggravated fatigue (12.7%) and malaise (10.9%). The most common adverse
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/15/2009)... Flextronics (Nasdaq: FLEX ) today ... announced acquisition of SloMedical S.R.O., a leading ... from tubing sets to complex devices for ... provides a broad set of capabilities to ... Terms of the deal were not disclosed. ...
(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...
(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global ... separation, safety and availability, announced today that the ... approval to market InterSol ® platelet additive ... solution is a specialized product used in combination ... vital blood component used to prevent or treat ...
Breaking Medicine Technology:Flextronics Completes SloMedical Acquisition 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Akerman Senterfitt Announces Expansion of Healthcare Practice 50071 1Akerman Senterfitt Announces Expansion of Healthcare Practice 50071 2Akerman Senterfitt Announces Expansion of Healthcare Practice 50071 3Virus filters for medical diagnosis 50068 1Virus filters for medical diagnosis 50068 2Engineering innovative solutions for 21st century medicine 9005 1Engineering innovative solutions for 21st century medicine 9005 2Engineering innovative solutions for 21st century medicine 9005 3Engineering innovative solutions for 21st century medicine 9005 4
... 1 Studies with Monoclonal Antibody,Targeting Interleukin-9 (IL-9); ... in Developing Potential Asthma,Therapies, GAITHERSBURG, Md., May ... the presentation of data,highlighting recent progress within ... two Phase 1 clinical,studies with its monoclonal ...
... WIRE)--May 24, 2007 - ImmunoGen, Inc.,(Nasdaq: IMGN), a ... Tumor-Activated Prodrug (TAP),technology, today announced that clinical findings ... solid tumors are to be,reported at the 43rd ... take place June 1-5, 2007 in Chicago, IL., ...
Other Medicine Technology:MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
(Date:12/16/2009)... for the Christmas rush Hallmark Cards have announced a great ... industry. With an easy to navigate website at www.hallmark.co.uk/specialoccasions , ... you with their own words and photos and then order as ... , ... Bradford, UK (PRWEB) December 16, 2009 -- Just ...
(Date:12/15/2009)... electrophoretic method for detecting MIRCERA and other erythropoietins ... SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but ... for detecting other EPOs. Details of this ... Anti-Doping Agency (WADA), appear in the latest issue ... by Wiley-Blackwell. , MIRCERA (methoxy polyethylene glycol-epoetin beta), ...
(Date:12/15/2009)... WASHINGTON, Dec. 15 The Food and Health ... Kong and overseas parties in developing private hospitals at ... The deadline for submitting EOI is March 31, 2010. ... Food and Health, Dr. York Chow, said the promotion ... under healthcare reform and a major Hong Kong government ...
(Date:12/15/2009)... YORK, Dec. 15 Vitech Systems Group, ... Relationship Management (CRM) software, announced today that it ... implementation for the Screen Actors Guild-Producers Pension & ... advanced customer service capabilities to SAG-PH call center ... system was installed using Vitech,s V3 Benefits Administration ...
(Date:12/15/2009)... released some sobering statistics concerning the parallel rise in diabetes and ... effective means of combating this trend afflicting their workforce. , ... ... diabetes are climbing across America due in large part to the ... Diabetes Association has stated that the rate of diabetes could be ...
Breaking Medicine News(10 mins):Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3
... Our ability to use objects and tools to perform actions ... to a level that is unique to our species. In ... National Center for Scientific Research (CNRS) and the Paris Descartes ... Cortex ( www.elsevier.com/locate/cortex ), researchers have found that ...
... named director of grants and foundation relations for the ... position, Widness will oversee a comprehensive grant-seeking program on ... with hospital leaders, ministry leaders and program staff, she ... submissions, track and evaluate those submissions and serve as ...
... Georgetown University Medical Center and the Lombardi ... the world,s most respected cancer researchers, V. Craig Jordan, ... as scientific director for the cancer center and vice ... scientific leadership is recognized the world over. He ...
... A new alliance between the world,s largest ... of unattended massage beds is focused on helping ... and affordable service to customers.(Photo: ... the HydroMassage, a massage system that features an ...
... Tracker(TM) provide macro- and micro-views to help ... Shared Health(R), one of the nation,s largest ... new technology tools, Clinical Insight(TM) and Condition ... into a system that helps physicians operate ...
... in Events in San Diego , New ... Free VelaShape Treatment Through End of April , FARMINGTON ... provider of aesthetic services in the U.S., announced its sponsorship ... total well-being blitz where thousands of active women converge in ...
Other Medicine News:Health News:Katherine Widness Named Director of Grants and Foundation Relations for the Sisters of Charity Health System 2Health News:Katherine Widness Named Director of Grants and Foundation Relations for the Sisters of Charity Health System 3Health News:V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetown's Lombardi Comprehensive Cancer Center 2Health News:V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetown's Lombardi Comprehensive Cancer Center 3Health News:V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetown's Lombardi Comprehensive Cancer Center 4Health News:V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetown's Lombardi Comprehensive Cancer Center 5Health News:ETS Tan Now Exclusive Distributor of HydroMassage in U.S. 2Health News:Shared Health(R) Adds Practice Management Tools to Clinical Xchange(TM) Platform 2Health News:Shared Health(R) Adds Practice Management Tools to Clinical Xchange(TM) Platform 3Health News:American Laser Centers Sponsors SELF Magazine's Workout in the Park 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: